ChlorprothixeneCAS# 113-59-7 |
- Dexpramipexole dihydrochloride
Catalog No.:BCC1528
CAS No.:104632-27-1
- Dexpramipexole
Catalog No.:BCC1527
CAS No.:104632-28-2
- Cariprazine hydrochloride
Catalog No.:BCC1454
CAS No.:1083076-69-0
- Cariprazine
Catalog No.:BCC1453
CAS No.:839712-12-8
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 113-59-7 | SDF | Download SDF |
PubChem ID | 667467 | Appearance | Powder |
Formula | C18H18ClNS | M.Wt | 315.87 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | DMSO : 33.33 mg/mL (105.52 mM; Need ultrasonic) H2O : < 0.1 mg/mL (insoluble) | ||
Chemical Name | (3Z)-3-(2-chlorothioxanthen-9-ylidene)-N,N-dimethylpropan-1-amine | ||
SMILES | CN(C)CCC=C1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl | ||
Standard InChIKey | WSPOMRSOLSGNFJ-AUWJEWJLSA-N | ||
Standard InChI | InChI=1S/C18H18ClNS/c1-20(2)11-5-7-14-15-6-3-4-8-17(15)21-18-10-9-13(19)12-16(14)18/h3-4,6-10,12H,5,11H2,1-2H3/b14-7- | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Chlorprothixene Dilution Calculator
Chlorprothixene Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.1659 mL | 15.8293 mL | 31.6586 mL | 63.3172 mL | 79.1465 mL |
5 mM | 0.6332 mL | 3.1659 mL | 6.3317 mL | 12.6634 mL | 15.8293 mL |
10 mM | 0.3166 mL | 1.5829 mL | 3.1659 mL | 6.3317 mL | 7.9146 mL |
50 mM | 0.0633 mL | 0.3166 mL | 0.6332 mL | 1.2663 mL | 1.5829 mL |
100 mM | 0.0317 mL | 0.1583 mL | 0.3166 mL | 0.6332 mL | 0.7915 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Chlorprothixene (Cloxan, Taractan, Truxal) is a typical antipsychotic drug of the thioxanthene class and was the first of the series to be synthesized.
- Estradiol diproppionate
Catalog No.:BCC8960
CAS No.:113-38-2
- IM-12
Catalog No.:BCC5487
CAS No.:1129669-05-1
- Tokinolide B
Catalog No.:BCN2753
CAS No.:112966-16-2
- Calcipotriol
Catalog No.:BCC1444
CAS No.:112965-21-6
- PD128907 HCl
Catalog No.:BCC4469
CAS No.:112960-16-4
- HU 211
Catalog No.:BCC5946
CAS No.:112924-45-5
- Boc-D-Asp(OcHex)-OH
Catalog No.:BCC3372
CAS No.:112898-18-7
- BzATP triethylammonium salt
Catalog No.:BCC7643
CAS No.:112898-15-4
- Raltitrexed
Catalog No.:BCC4457
CAS No.:112887-68-0
- Mosapride Citrate
Catalog No.:BCC1065
CAS No.:112885-42-4
- Mosapride
Catalog No.:BCC4078
CAS No.:112885-41-3
- Fmoc-2-Nal-OH
Catalog No.:BCC3292
CAS No.:112883-43-9
- Chlorpheniramine Maleate
Catalog No.:BCC4526
CAS No.:113-92-8
- Potassium benzylpenicillin
Catalog No.:BCC9126
CAS No.:113-98-4
- VU 0155069
Catalog No.:BCC7715
CAS No.:1130067-06-9
- 7-O-Methylrosmanol
Catalog No.:BCN7276
CAS No.:113085-62-4
- 3-Deoxysappanone B
Catalog No.:BCN6012
CAS No.:113122-54-6
- (S)-(+)-Niguldipine hydrochloride
Catalog No.:BCC6947
CAS No.:113145-69-0
- Physalin L
Catalog No.:BCN2312
CAS No.:113146-74-0
- nor-Binaltorphimine dihydrochloride
Catalog No.:BCC6614
CAS No.:113158-34-2
- Linopirdine dihydrochloride
Catalog No.:BCC7231
CAS No.:113168-57-3
- PPPA
Catalog No.:BCC7309
CAS No.:113190-92-4
- H-Phe(4-F)-OH
Catalog No.:BCC3216
CAS No.:1132-68-9
- (3R)-Hydrangenol 8-O-glucoside pentaacetate
Catalog No.:BCN1617
CAS No.:113270-98-7
Chlorprothixene in bodies after exhumation.[Pubmed:23821789]
Forensic Sci Int. 2013 Jun 10;229(1-3):e30-4. Epub 2013 Apr 28.
Toxicological analyses on body tissues and interpretation of results after exhumation are a challenging task. We report five cases in which toxicological analyses had to be performed due to suspicion of homicide by Chlorprothixene intoxication. Exhumations had to be carried out following post mortem intervals in earth graves between two and five and a half years. Chlorprothixene and in some cases also its metabolites could be detected in liver and brain. For the interpretation of the results, Chlorprothixene concentrations determined in brain should be used because of a relative isolation of the brain within the skull. However, a loss of organ weights due to post mortem degradation, which may lead to an increase of drug levels, should be taken into account.
Intrathecal chlorprothixene, cis(z)-flupenthixol, chlorpromazine and fluphenazine for prolonged spinal blockades of sensory and motor functions in rats.[Pubmed:22926199]
Eur J Pharmacol. 2012 Oct 15;693(1-3):31-6.
The aim of this study was to examine whether thioxanthine-type antipsychotics (Chlorprothixene and cis(z)-flupenthixol) and phenothiazine-type antipsychotics (chlorpromazine and fluphenazine) produced spinal anesthesia. Using a rat model of intrathecal injection, we evaluated spinal anesthesia of antipsychotic drugs (Chlorprothixene, cis(z)-flupenthixol, chlorpromazine, and fluphenazine) and bupivacaine, a known local anesthetic. At a same dose of 2.31 mumol/kg, Chlorprothixene had the most potent spinal blockades (P<0.001) and the longest duration of action (P<0.001) of motor function and nociception among those antipsychotic drugs. On the 50% effective dose (ED(50)) basis, the ranks of potencies were Chlorprothixene=bupivacaine>cis(z)-flupenthixol>chlorpromazine>fluphenazine (P<0.01 for the differences) in dose-response studies. At an equianesthetic basis (ED(25), ED(50), and ED(75)), the spinal block duration caused by Chlorprothixene, cis(z)-flupenthixol, chlorpromazine or fluphenazine was longer than that caused by bupivacaine (P<0.05). These results showed that Chlorprothixene produced a similar potency and longer duration of spinal anesthesia than did bupivacaine, whereas several other antipsychotics produced less potency than did bupivacaine.
Postmortem femoral blood reference concentrations of aripiprazole, chlorprothixene, and quetiapine.[Pubmed:25342720]
J Anal Toxicol. 2015 Jan-Feb;39(1):41-4.
Postmortem femoral blood concentrations of the antipsychotic drugs aripiprazole, Chlorprothixene and its metabolite, and quetiapine were determined by LC-MS-MS in 25 cases for aripiprazole and 60 cases each for Chlorprothixene and quetiapine. For cases where the cause of death was not related to the considered drugs, the following blood concentration intervals (10-90 percentiles) were observed: 0.049-0.69 mg/kg for aripiprazole, 0.006-0.24 mg/kg for Chlorprothixene, and 0.006-0.37 mg/kg for quetiapine. These concentration ranges largely correspond to therapeutic plasma levels observed in vivo suggesting no or only limited postmortem redistribution for aripiprazole, Chlorprothixene with metabolite, and quetiapine in these cases. One fatality caused by Chlorprothixene with a blood level of 0.90 mg/kg was recorded, and in six cases Chlorprothixene was judged to be contributing to death with concentrations 0.43-0.91 mg/kg. No fatalities exclusively ascribed to the two other drugs were observed, but aripiprazole was considered to be contributing to death in one case (1.9 mg/kg) and quetiapine in seven cases with concentrations 0.35-10.0 mg/kg. The presented values may serve as a reference for judgment of postmortem cases with presence of these antipsychotics.
Thioxanthenes, chlorprothixene and flupentixol inhibit proton currents in BV2 microglial cells.[Pubmed:26945819]
Eur J Pharmacol. 2016 May 15;779:31-7.
The thioxanthene antipsychotic drugs Chlorprothixene and flupentixol have anti-inflammatory and antioxidant properties. The reactive oxygen species produced by NADPH oxidase during microglia-mediated inflammatory responses cause neuronal damage, thereby contributing to various neurodegenerative diseases. Voltage-gated proton channels sustain the NADPH oxidase activity, and inhibition of the channels' activity reduces the production of reactive oxygen species. Herein, the effects of Chlorprothixene and flupentixol on proton currents were investigated in BV2 microglial cells using the whole-cell patch-clamp method. Both drugs inhibited the proton currents in a concentration-dependent manner (IC50=1.7muM and 6.6muM, respectively). Chlorprothixene at 3muM slightly shifted the activation voltage toward depolarization. Both the activation and the deactivation kinetics of the proton currents were slowed by Chlorprothixene 1.2- and 3.5-fold, respectively. Thus, the inhibition of proton currents may be partly responsible for the antioxidant effects of thioxanthene antipsychotic drugs.